These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 9672063)
1. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063 [TBL] [Abstract][Full Text] [Related]
2. Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Lijnen HR; Silence J; Lemmens G; Frederix L; Collen D Thromb Haemost; 1998 Jun; 79(6):1171-6. PubMed ID: 9657444 [TBL] [Abstract][Full Text] [Related]
3. Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury. Lijnen HR Verh K Acad Geneeskd Belg; 2001; 63(6):605-22. PubMed ID: 11813512 [TBL] [Abstract][Full Text] [Related]
4. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177 [TBL] [Abstract][Full Text] [Related]
5. Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants. Mazzieri R; Masiero L; Zanetta L; Monea S; Onisto M; Garbisa S; Mignatti P EMBO J; 1997 May; 16(9):2319-32. PubMed ID: 9171346 [TBL] [Abstract][Full Text] [Related]
6. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560 [TBL] [Abstract][Full Text] [Related]
7. Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice. Lijnen HR; Silence J; Van Hoef B; Collen D Blood; 1998 Mar; 91(6):2045-53. PubMed ID: 9490689 [TBL] [Abstract][Full Text] [Related]
8. Plasminogen and plasmin activity in patients with coronary artery disease. Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973 [TBL] [Abstract][Full Text] [Related]
9. Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. Lim YT; Sugiura Y; Laug WE; Sun B; Garcia A; DeClerck YA J Cell Physiol; 1996 May; 167(2):333-40. PubMed ID: 8613475 [TBL] [Abstract][Full Text] [Related]
10. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner. Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685 [TBL] [Abstract][Full Text] [Related]
11. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis. Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572 [TBL] [Abstract][Full Text] [Related]
12. Different mechanisms of increased luminal stenosis after arterial injury in mice deficient for urokinase- or tissue-type plasminogen activator. Schäfer K; Konstantinides S; Riedel C; Thinnes T; Müller K; Dellas C; Hasenfuss G; Loskutoff DJ Circulation; 2002 Oct; 106(14):1847-52. PubMed ID: 12356640 [TBL] [Abstract][Full Text] [Related]
13. Receptor-independent role of urokinase-type plasminogen activator in pericellular plasmin and matrix metalloproteinase proteolysis during vascular wound healing in mice. Carmeliet P; Moons L; Dewerchin M; Rosenberg S; Herbert JM; Lupu F; Collen D J Cell Biol; 1998 Jan; 140(1):233-45. PubMed ID: 9425170 [TBL] [Abstract][Full Text] [Related]
14. Staphylokinase reduces plasmin formation by endogenous plasminogen activators. Jin T; Bokarewa M; Zhu Y; Tarkowski A Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597 [TBL] [Abstract][Full Text] [Related]
15. Plasmin is not protective in experimental renal interstitial fibrosis. Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414 [TBL] [Abstract][Full Text] [Related]
16. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Baricos WH; Cortez SL; el-Dahr SS; Schnaper HW Kidney Int; 1995 Apr; 47(4):1039-47. PubMed ID: 7540230 [TBL] [Abstract][Full Text] [Related]
17. Vascular extracellular matrix remodeling in cerebral aneurysms. Bruno G; Todor R; Lewis I; Chyatte D J Neurosurg; 1998 Sep; 89(3):431-40. PubMed ID: 9724118 [TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. Ginestra A; Monea S; Seghezzi G; Dolo V; Nagase H; Mignatti P; Vittorelli ML J Biol Chem; 1997 Jul; 272(27):17216-22. PubMed ID: 9202045 [TBL] [Abstract][Full Text] [Related]
19. Reduced transplant arteriosclerosis in plasminogen-deficient mice. Moons L; Shi C; Ploplis V; Plow E; Haber E; Collen D; Carmeliet P J Clin Invest; 1998 Nov; 102(10):1788-97. PubMed ID: 9819364 [TBL] [Abstract][Full Text] [Related]
20. Investigations on the Role of the Fibrinolytic Pathway on Outflow Facility Regulation. Hu Y; Barron AO; Gindina S; Kumar S; Chintala S; Nayyar A; Danias J Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1571-1580. PubMed ID: 30995314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]